PL377138A1 - Sposób otrzymywania pochodnych 1-N-(fenylo)-2-N-(fenylo)pirolidyno-1,2-dikarboksyamidowych oraz pochodnych kwasu 1-(fenylokarbamoylo)-pirolidyno-2-karboksylowego jako związków pośrednich - Google Patents

Sposób otrzymywania pochodnych 1-N-(fenylo)-2-N-(fenylo)pirolidyno-1,2-dikarboksyamidowych oraz pochodnych kwasu 1-(fenylokarbamoylo)-pirolidyno-2-karboksylowego jako związków pośrednich

Info

Publication number
PL377138A1
PL377138A1 PL377138A PL37713804A PL377138A1 PL 377138 A1 PL377138 A1 PL 377138A1 PL 377138 A PL377138 A PL 377138A PL 37713804 A PL37713804 A PL 37713804A PL 377138 A1 PL377138 A1 PL 377138A1
Authority
PL
Poland
Prior art keywords
pyrrolidine
amide
phenyl
derivatives
phenylcarbamoyl
Prior art date
Application number
PL377138A
Other languages
English (en)
Inventor
Werner Mederski
Christos Tsaklakidis
Dieter Dorsch
Bertram Cezanne
Johannes Gleitz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10315377A external-priority patent/DE10315377A1/de
Priority claimed from DE10327428A external-priority patent/DE10327428A1/de
Priority claimed from DE2003129295 external-priority patent/DE10329295A1/de
Priority claimed from DE2003134174 external-priority patent/DE10334174A1/de
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL377138A1 publication Critical patent/PL377138A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL377138A 2003-04-03 2004-03-09 Sposób otrzymywania pochodnych 1-N-(fenylo)-2-N-(fenylo)pirolidyno-1,2-dikarboksyamidowych oraz pochodnych kwasu 1-(fenylokarbamoylo)-pirolidyno-2-karboksylowego jako związków pośrednich PL377138A1 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10315377A DE10315377A1 (de) 2003-04-03 2003-04-03 Carbonylverbindungen
DE10327428A DE10327428A1 (de) 2003-06-18 2003-06-18 Ethinylprolinderivate
DE2003129295 DE10329295A1 (de) 2003-06-30 2003-06-30 Carbonylverbindungen
DE10329457A DE10329457A1 (de) 2003-04-03 2003-07-01 Ethinylprolinderivate
DE2003134174 DE10334174A1 (de) 2003-07-26 2003-07-26 Pyrrolidinderivate und Verfahren zur Herstellung

Publications (1)

Publication Number Publication Date
PL377138A1 true PL377138A1 (pl) 2006-01-23

Family

ID=33136213

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377138A PL377138A1 (pl) 2003-04-03 2004-03-09 Sposób otrzymywania pochodnych 1-N-(fenylo)-2-N-(fenylo)pirolidyno-1,2-dikarboksyamidowych oraz pochodnych kwasu 1-(fenylokarbamoylo)-pirolidyno-2-karboksylowego jako związków pośrednich

Country Status (16)

Country Link
US (1) US7504500B2 (pl)
EP (1) EP1608646B1 (pl)
JP (1) JP4634369B2 (pl)
KR (1) KR20050118709A (pl)
AR (1) AR043831A1 (pl)
AT (1) ATE366732T1 (pl)
AU (1) AU2004226280B2 (pl)
BR (1) BRPI0408888A (pl)
CA (1) CA2520893C (pl)
DE (2) DE10329457A1 (pl)
ES (1) ES2287708T3 (pl)
MX (1) MXPA05010433A (pl)
PE (1) PE20050395A1 (pl)
PL (1) PL377138A1 (pl)
TW (1) TW200500339A (pl)
WO (1) WO2004087695A1 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050119266A1 (en) * 2003-10-01 2005-06-02 Yan Shi Pyrrolidine and piperidine derivatives as factor Xa inhibitors
DE102004004731A1 (de) * 2004-01-30 2005-08-18 Merck Patent Gmbh Harnstoffderivate
DE102004045796A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
DE102004047254A1 (de) * 2004-09-29 2006-04-13 Merck Patent Gmbh Carbonylverbindungen
DE102004050283A1 (de) * 2004-10-15 2006-04-27 Lanxess Deutschland Gmbh 4-Aminophenyl-morpholinon-Derivate und deren Herstellung
US7301817B2 (en) 2005-10-27 2007-11-27 Sandisk Corporation Method for programming of multi-state non-volatile memory using smart verify
EP1951717A1 (en) * 2005-11-16 2008-08-06 F.Hoffmann-La Roche Ag Novel pyrrolidine derivatives as inhibitors of coagulation factor xa
EP1818330A1 (de) * 2006-02-14 2007-08-15 Boehringer Ingelheim Pharma GmbH & Co.KG Substituierte Prolinamide, deren Herstellung und deren Verwendung als Arzneimittel
BRPI0711648A2 (pt) 2006-05-16 2011-11-29 Boehringer Ingelheim Int prolinamidas substituìdas, fabricação e uso das mesmas como medicamentos
US8673920B2 (en) 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9073882B2 (en) 2010-10-27 2015-07-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2012058134A1 (en) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
CN103874493A (zh) 2011-08-19 2014-06-18 默沙东公司 肾外髓质钾通道的抑制剂
US9527830B2 (en) 2011-09-16 2016-12-27 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2771004B1 (en) 2011-10-25 2016-05-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US8999990B2 (en) 2011-10-25 2015-04-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9108947B2 (en) 2011-10-31 2015-08-18 Merck Sharp & Dohme Corp. Inhibitors of the Renal Outer Medullary Potassium channel
WO2013066718A2 (en) 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2773199B1 (en) 2011-10-31 2019-04-10 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013090271A1 (en) 2011-12-16 2013-06-20 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
EP2925322B1 (en) 2012-11-29 2018-10-24 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2934533B1 (en) 2012-12-19 2017-11-15 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9604998B2 (en) 2013-02-18 2017-03-28 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2014150132A1 (en) 2013-03-15 2014-09-25 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9751881B2 (en) 2013-07-31 2017-09-05 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9951052B2 (en) 2013-10-31 2018-04-24 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822111B2 (ja) * 1977-10-29 1983-05-06 協和醗酵工業株式会社 柑橘類果実の改質剤
JPS63232846A (ja) * 1987-03-20 1988-09-28 Haruo Ogura 新規な固定相担体
AU4966497A (en) * 1996-11-18 1998-06-10 Yamanouchi Pharmaceutical Co., Ltd. Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
US7030141B2 (en) * 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade

Also Published As

Publication number Publication date
AU2004226280B2 (en) 2010-06-17
JP4634369B2 (ja) 2011-02-16
CA2520893C (en) 2012-07-10
ES2287708T3 (es) 2007-12-16
ATE366732T1 (de) 2007-08-15
DE502004004294D1 (de) 2007-08-23
EP1608646B1 (de) 2007-07-11
US20060211692A1 (en) 2006-09-21
AU2004226280A1 (en) 2004-10-14
BRPI0408888A (pt) 2006-04-11
JP2006522037A (ja) 2006-09-28
PE20050395A1 (es) 2005-06-04
CA2520893A1 (en) 2004-10-14
TW200500339A (en) 2005-01-01
EP1608646A1 (de) 2005-12-28
KR20050118709A (ko) 2005-12-19
DE10329457A1 (de) 2005-01-20
WO2004087695A1 (de) 2004-10-14
US7504500B2 (en) 2009-03-17
AR043831A1 (es) 2005-08-17
MXPA05010433A (es) 2005-11-04

Similar Documents

Publication Publication Date Title
PL377138A1 (pl) Sposób otrzymywania pochodnych 1-N-(fenylo)-2-N-(fenylo)pirolidyno-1,2-dikarboksyamidowych oraz pochodnych kwasu 1-(fenylokarbamoylo)-pirolidyno-2-karboksylowego jako związków pośrednich
ZA200508888B (en) Methods for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
WO2006071762A3 (en) Pyrimidine-based inhibitors of dipeptidyl peptidase iv and methods
EP1592689A4 (en) 3-AMINO-4-PHENYLBUTANOIC ACID DERIVATIVES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE FOR THE TREATMENT OR PREVENTION OF DIABETES
EP1589969A4 (en) 3-AMINO-4-PHENYLBUTANEAN DERIVATEALS DIPEPTIDYLPEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
WO2005030751A3 (en) Dipeptidyl peptidase inhibitors
AU2003232405A1 (en) Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
EP1583534A4 (en) 3-AMINO-4-PHENYLBUTANIC ACID DERIVATIVES AS DIPEPTIDYL-PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
AU2003286776A1 (en) Novel inhibitors of dipeptidyl peptidase iv
IL174608A0 (en) Pyridine compounds as inhibitors of dipeptidyl peptidase iv
IL161158A0 (en) N - substituted pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors
WO2007075895A3 (en) Heterocyclic derivatives as modulators of ion channels
EP1997533B8 (en) Heterocyclic boronic acid compounds, dipeptidyl peptidase IV inhibitors
SI2505579T1 (sl) Postopki in spojine za izdelavo inhibitorjev dipeptidil peptidaze IV in njihovih vmesnih spojin
EP1551801A4 (en) NOVEL GAMMA-LACTAMES AS INHIBITORS OF BETA-SECRETASE
EP1881975B8 (en) N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
WO2007053819A3 (en) Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods
IL165887A0 (en) Novel tetrahydropyridine derivatives as renin inhibitors
IL172018A0 (en) Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
WO2006130493A3 (en) Heterocycles useful as modulators of ion channels
AU2003903242A0 (en) Process for the treatment of wood
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
HUP0401525A2 (en) Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them
IL173631A0 (en) Crystal forms of 1-methyl carbapenem, processes for the preparation thereof and pharmaceutical compositions containing the same
AU2003237595A1 (en) Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)